Literature DB >> 9170198

Cytokines in primary biliary cirrhosis.

P A Berg1, R Klein, M Röcken.   

Abstract

Immunoreactivity to intra- and extracellular antigens is regulated mainly by two different types of T-helper cells, namely TH1 (producing mainly IFN-gamma and Il-2) and TH2 (producing IL-4, -5, -10). Both types cross-regulate each other. TH1 mechanisms seem to be involved principally in organ-specific autoaggressive disorders, while TH2 response is an expression of allergic conditions characterized by eosinophilic reactions and increased IgE levels. There are only a few reports dealing with cytokine profiles in patients with primary biliary cirrhosis (PBC). From studies analyzing the cytokine gene expression and cytokines in supernatants of nonstimulated and antigen-specific lymphocytes derived from the affected liver or peripheral blood of PBC patients, there is evidence that, in the course of the disease, predominantly TH1 cells are activated. However, in view of the eosinophilic reaction observed especially in patients with early PBC, it may well be that a switch from TH2 to TH1 occurs. Concerning the regulatory function of TH1/TH2 cells, a more refined evaluation of these T-cell subsets could help to provide a new insight into the natural course of PBC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9170198     DOI: 10.1055/s-2007-1007189

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  14 in total

1.  Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis.

Authors:  T Yamano; T Higashi; K Nouso; H Nakatsukasa; K Kariyama; E Yumoto; Y Kobayashi; K Yamamoto; H Iwagaki; T Yagi; T Tanimoto; M Kurimoto; N Tanaka; T Tsuji
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Methods for the in vitro determination of an individual disposition towards TH1- or TH2-reactivity by the application of appropriate stimulatory antigens.

Authors:  H Barth; P A Berg; R Klein
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

3.  Anti-mitochondrial antibodies in patients with dilated cardiomyopathy (anti-M7) are directed against flavoenzymes with covalently bound FAD.

Authors:  A Otto; I Stähle; R Klein; P A Berg; S Pankuweit; R Brandsch
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

4.  Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis.

Authors:  X Bo; U Broome; M Remberger; S Sumitran-Holgersson
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 5.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

6.  Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression.

Authors:  N A Shackel; P H McGuinness; C A Abbott; M D Gorrell; G W McCaughan
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

7.  Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis.

Authors:  Lindsey Kennedy; Heather Francis; Pietro Invernizzi; Julie Venter; Nan Wu; Marco Carbone; M Eric Gershwin; Francesca Bernuzzi; Antonio Franchitto; Domenico Alvaro; Marco Marzioni; Paolo Onori; Eugenio Gaudio; Amelia Sybenga; Luca Fabris; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  FASEB J       Date:  2019-06-28       Impact factor: 5.191

Review 8.  The immunology of primary biliary cirrhosis: the end of the beginning?

Authors:  J M Palmer; J A Kirby; D E J Jones
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Glucocorticoid receptors are downregulated in hepatic T lymphocytes in rats with experimental cholangitis.

Authors:  K Tjandra; T Le; M G Swain
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 10.  Liver architecture, cell function, and disease.

Authors:  Hiromi Ishibashi; Minoru Nakamura; Atsumasa Komori; Kiyoshi Migita; Shinji Shimoda
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.